| Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 … C Allemani, T Matsuda, V Di Carlo, R Harewood, M Matz, M Nikšić, ... The Lancet 391 (10125), 1023-1075, 2018 | 3975 | 2018 |
| Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study M Arnold, MJ Rutherford, A Bardot, J Ferlay, TML Andersson, ... The Lancet Oncology 20 (11), 1493-1505, 2019 | 777 | 2019 |
| A systematic review of prognostic/end-of-life communication with adults in the advanced stages of a life-limiting illness: patient/caregiver preferences for the content, style … SM Parker, JM Clayton, K Hancock, S Walder, PN Butow, S Carrick, ... Journal of pain and symptom management 34 (1), 81-93, 2007 | 631 | 2007 |
| Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea AP Abernethy, DC Currow, P Frith, BS Fazekas, A McHugh, C Bui Bmj 327 (7414), 523-528, 2003 | 610 | 2003 |
| Integration of oncology and palliative care: a Lancet Oncology Commission S Kaasa, JH Loge, M Aapro, T Albreht, R Anderson, E Bruera, C Brunelli, ... The lancet oncology 19 (11), e588-e653, 2018 | 590 | 2018 |
| Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004–2007 S Walters, C Maringe, MP Coleman, MD Peake, J Butler, N Young, ... Thorax 68 (6), 551-564, 2013 | 587 | 2013 |
| Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial AP Abernethy, CF McDonald, PA Frith, K Clark, JE Herndon, J Marcello, ... The Lancet 376 (9743), 784-793, 2010 | 551 | 2010 |
| Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials JS Temel, AP Abernethy, DC Currow, J Friend, EM Duus, Y Yan, ... The Lancet Oncology 17 (4), 519-531, 2016 | 545 | 2016 |
| Physical, psychosocial, relationship, and economic burden of caring for people with cancer: a review A Girgis, S Lambert, C Johnson, A Waller, D Currow Journal of oncology practice 9 (4), 197-202, 2013 | 515 | 2013 |
| Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial JS Kutner, PJ Blatchford, DH Taylor, CS Ritchie, JH Bull, DL Fairclough, ... JAMA internal medicine 175 (5), 691-700, 2015 | 509 | 2015 |
| The Australia-modified Karnofsky Performance Status (AKPS) scale: a revised scale for contemporary palliative care clinical practice [ISRCTN81117481] AP Abernethy, T Shelby-James, BS Fazekas, D Woods, DC Currow BMC palliative care 4 (1), 1-12, 2005 | 508 | 2005 |
| Truth-telling in discussing prognosis in advanced life-limiting illnesses: a systematic review K Hancock, JM Clayton, SM Parker, S Wal der, PN Butow, S Carrick, ... Palliative medicine 21 (6), 507-517, 2007 | 505 | 2007 |
| Palliative cancer care a decade later: accomplishments, the need, next steps--from the American Society of Clinical Oncology FD Ferris, E Bruera, N Cherny, C Cummings, D Currow, D Dudgeon, ... J clin oncol 27 (18), 3052-3058, 2009 | 478 | 2009 |
| Clinical practice guidelines for communicating prognosis and end-of-life issues with adults in the advanced stages of a life-limiting illness, and their caregivers JM Clayton, KM Hancock, PN Butow, MHN Tattersall, DC Currow The Medical Journal of Australia 186 (12), S77, 2007 | 459 | 2007 |
| Sustaining hope when communicating with terminally ill patients and their families: a systematic review JM Clayton, K Hancock, S Parker, PN Butow, S Walder, S Carrick, ... Psycho‐Oncology: Journal of the Psychological, Social and Behavioral …, 2008 | 419 | 2008 |
| Randomized controlled trial of a prompt list to help advanced cancer patients and their caregivers to ask questions about prognosis and end-of-life care JM Clayton, PN Butow, MHN Tattersall, RJ Devine, JM Simpson, ... Journal of Clinical Oncology 25 (6), 715-723, 2007 | 391 | 2007 |
| Efficacy of oral risperidone, haloperidol, or placebo for symptoms of delirium among patients in palliative care: a randomized clinical trial MR Agar, PG Lawlor, S Quinn, B Draper, GA Caplan, D Rowett, ... JAMA internal medicine 177 (1), 34-42, 2017 | 335 | 2017 |
| Health-related quality of life measured using the EQ-5D–5L: South Australian population norms N McCaffrey, B Kaambwa, DC Currow, J Ratcliffe Health and quality of life outcomes 14 (1), 1-12, 2016 | 328 | 2016 |
| Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study DC Currow, C McDonald, S Oaten, B Kenny, P Allcroft, P Frith, M Briffa, ... Journal of pain and symptom management 42 (3), 388-399, 2011 | 319 | 2011 |
| Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study MP Ekström, A Bornefalk-Hermansson, AP Abernethy, DC Currow Bmj 348, 2014 | 316 | 2014 |
Miriam JohnsonHull York Medical SchoolVerified email at hyms.ac.uk
